BNET Industries
Medicines Co. (MDCO) is in the Pharma Industry
- Revenue
- Dec 31 2007
- $257.5M
- Profit
- Dec 31 2007
- ($18.2M)
- Market Cap
- Sep 04 2008
- $1.2B
Latest News and Analysis
The Medicines Company Q1 2008 Earnings Conference Call Transcript
The Medicines Company Q1 2008 Earnings Conference Call Transcript
The Medicines Company Q4 2007 Earnings Call Transcript
The Medicines Company Q4 2007 Earnings Call Transcript
Additional Resources
Injected Drug Approved for High Blood Pressure
The U.S. Food and Drug Administration has approved Cleviprex clevidipine butyrate, an injected drug to treat high blood pressure. Produced by the Medicines Co. of Parsippany, N.J., the drug is to be prescribed when oral high blood pressure drugs aren't possible or desired. Unlike many older drugs for high...
Meditation, Yoga Might Switch Off Stress Genes
Researchers say they've taken a significant stride forward in understanding how relaxation techniques such as meditation, prayer and yoga improve health: by changing patterns of gene activity that affect how the body responds to stress. The changes were seen both in long-term practitioners and in newer recruits, the scientists...
The North American Menopause Society Issues New Recommendations Regarding Management of Breast Cancer Risk in Postmenopausal Women
CLEVELAND -- The North American Menopause Society NAMS has just released a supplement to its official journal Menopause to meet the need for current clinical recommendations for managing breast cancer risk in postmenopausal women. Breast cancer is the most common cancer among women, except for...
Expert Consensus Panel Recommendation for Incorporating Lp-PLA2 Testing into Cardiovascular Disease Risk Assessment Guidelines
SOUTH SAN FRANCISCO, Calif., June 23 /PRNewswire/ -- diaDexus, Inc. today announced the release of a supplement to The American Journal of Cardiology, Vol. 101, No 12A June 16, 2008 that includes an expert consensus panel recommendation to include testing for lipoprotein-associated phospholipase A2 (Lp-PLA2), a...
Gay Men, Straight Women Have Similar Brains
MONDAY, June 16 HealthDay News - MRI and PET scan studies are showing remarkable similarities between the brains of gay men and straight women, and between those of lesbians and straight men. For example, the brains of straight men and of gay women share certain common features: both are...
Antibiotics Can Prevent Wound Complications of Childbirth, Stanford/Packard Study Finds
STANFORD, Calif. -- A single dose of antibiotics can significantly aid healing of the severe tearing that occurs in vaginal tissues during many births, according to researchers at Lucile Packard Children's Hospital at Stanford, the Stanford University School of Medicine and Santa Clara Valley Medical Center. The...
Intense Blood Glucose Control Yields No Significant Effect on CVD Reduction in VA Diabetes Trial
A major long-term U.S. clinical trial tostudy whether intense control of blood glucose in type 2 diabetes would reduce the risk of cardiovasculardisease found a reduction in cardiovascular events, but it was notstatistically significant, according to a report presented here today atthe American...
Pearson's thoracic & esophageal surgery, 3d ed.; 2v
Pearson's thoracic & esophageal surgery, 3d ed.; 2v. Patterson, G. Alexander et al. Churchill Livingstone 2008 2766 pages $379.00 Hardcover RD539 Earlier editions published in 1995 and 2002 were titled Esophageal...
Research and Markets: Company Study of Huadong Medicine Is Available Now
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c92241) has announced the addition of "Company Study of Huadong Medicine" to their offering. Huadong Medicine Co., Ltd. was founded in March, 1993, based on the medicine distribution network in Hanzhou, capital of Zhejiang province, after a government-oriented restructuring. On December 22,...
Kiwa Bio-Tech Confirms Joint Venture Agreement With Shijiazhuang Huaxing Animal Medicine Co., Ltd
BEIJING and CLAREMONT, Calif., May 13 /Xinhua-PRNewswire-FirstCall/ -- Kiwa Bio-Tech Products Group Corporation (BULLETIN BOARD: KWBT) announced finalization of an agreement establishing a joint venture company capable of producing Kiwa's AF-01 anti-viral product. On May 9, General Manager of Shijiazhuang Huaxing Animal Medicine Co., Ltd. (''Huaxing''),...
Professors Marc Feldmann and Sir Ravinder Maini Named Winners of the 2008 Dr. Paul Janssen Award for Biomedical Research
NEW YORK, May 13 /PRNewswire/ -- Johnson & Johnson today announced that Professor Marc Feldmann, FMedSci, FAA, FRS and Emeritus Professor Sir Ravinder N. Maini, FRCP, FMedSci, FRS of the Kennedy Institute of Rheumatology, Imperial College London have been named the recipients of the 2008 Dr....
HUADONG MEDICINE PLANS TO CONTROL BOHUA PHARM
AsiaInfo Services04-04-2008Huadong Medicine Plans to Control Bohua PharmSHENZHEN, Apr 04, 2008 SinoCast via COMTEX -- Chinese pharmaceutical manufacturer Huadong Medicine Co., Ltd. (SZSE: 000963) today announced that it planned to take a 78.87 percent stake in its domestic peer Xi'an Bohua Pharmaceutical Co., Ltd.Besides, it intends to take over a...
Tongjitang Chinese Medicines Co. Review in Progress.
M2 PRESSWIRE-26 March 2008-Streetinvesting.com: Tongjitang Chinese Medicines Co. Review in ProgressC1994-2008 M2 COMMUNICATIONS LTD RDATE:26032008 Streetinvesting.com has now resumed our progressive review of Tongjitang Chinese Medicines Co. (NYSE:TCM) as it opened up $0.09 on below average volume early trading...
TONG REN TANG TO START PRODUCTION IN HONG KONG
AsiaInfo Services01-18-2008Tong Ren Tang to Start Production in Hong KongHong Kong January 17, Jan 18, 2008 SinoCast via COMTEX -- Beijing Tong Ren Tang Chinese Medicine Co., Ltd. have been fully qualified to start production in Hong Kong, according to one of its founders, Beijing Tongrentang Co., Ltd.(SHSE: 600085), a...
Merck's Investigational Extended-Release Niacin/Laropiprant Coadministered with Simvastatin Had Significant Additive Effects on LDL-C, HDL-C and Triglycerides in Phase III Study
Study Supports Development of CORDAPTIVE Coadministered with Simvastatin WHITEHOUSE STATION, N.J. -- Extended-release niacin/laropiprant (CORDAPTIVE[TM]) coadministered with simvastatin had significant additive effects on reducing LDL-cholesterol (LDL-C), increasing HDL-cholesterol (HDL-C) and reducing triglyceride levels in a Phase III study with patients with primary hypercholesterolemia or mixed...
TONGJITANG STARTS FDA CERTIFICATION
AsiaInfo Services10-25-2007Tongjitang Starts FDA CertificationGUIZHOU, Oct 25, 2007 SinoCast via COMTEX -- Tongjitang Chinese Medicines Co., Ltd. (NYSE: TCM), a leading traditional Chinese medicine manufacturer in China, has kicked off the formal procedure of FDA certification for its core product Xianlinggubao, a compound preparation of Chinese herbs with Epimedium grandiflorum...
Transoma Medical Receives FDA Marketing Clearance for Sleuth™ Implantable ECG Monitoring System
Wireless Remote ECG Monitoring System Enables Physicians to Diagnose Unexplained Fainting in Patients at Home and Work First Truly Wireless Implantable Monitoring System for Patients Represents a Significant Technology Advancement ST. PAUL, Minn. -- Transoma Medical, the leader in implantable wireless monitoring systems...
CEW honors beauty winners: award shows and charity events honor the individual contributions to beauty industry.(LIVE from NEW YORK)
Cosmetic Executive Women CEW celebrated the most innovative beauty product launches of the year on May 2 at New York's Waldorf-Astoria. The electricity was palpable at the celebratory luncheon hosted by Sex and the City star Mario Cantone; and introduced by Carlotta Jacobson,...
- Next »
- page 1 of 1
- « Previous
Sort byClose
- Incorporated: 1996
- CEO: Dr. Clive A. Meanwell Ph.D.
Medicines is a pharmaceutical company engaged in providing acute care hospital products. As of Dec 31 2007, Co. had one marketed product, Angiomax® (bivalirudin), which is an intravenous direct thrombin inhibitor used as an anticoagulant in combination with aspirin in patients undergoing percutaneous coronary interventions. Also, at Dec 31 2007, Co. had two products in late-stage development: Cleviprex™ (clevidipine), which is intended for the treatment of acute elevations in blood pressure when oral therapy is not desirable or feasible; and cangrelor, an intravenous antiplatelet agent that is intended to prevent platelet activation and aggregation.
Key Competitors
Medicines Co. Company Info
Board of Directors
Dr. Clive A. Meanwell Ph.D.
Chairman
Dr. Melvin K. Spigelman M.D.
Mr. Robert J. Hugin
Ms. Elizabeth H. S. Wyatt
Mr. William W. Crouse
Dr. T. Scott Johnson
Mr. John P. Kelley
Mr. Hiroaki Shigeta
Mr. Armin M. Kessler
Mr. Robert G. Savage
Contact Information
8 Campus Drive
Parsippany, NJ
http://www.themedicinescompany.com
973 656-1616